Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters
2022-08-30
999+
学术论著
上一篇：Immunogenicity correlation in cynomolgus monkeys between Luminex‐d total IgG immunoassay and pseudovirion‐ d neutralization assay for a 14‐valent recombinant human papillomavirus vaccine
下一篇：Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second line therapy in advanced esophageal squamous cell cancer
最新资讯
-
Efficacy Safety and Pharmacokinetics of Recombinant Human Coagulation Factor VIII (Omfiloctocog alfa) in Previously Treated Children with Severe Hemophilia A.
2022-08-30 -
Rational Development of a Polysaccharide-Protein-Conjugated Nanoparticle Vaccine Against SARS-CoV-2 Variants and Streptococcus pneumoniae
2022-08-30 -
Immunogenicity correlation in cynomolgus monkeys between Luminex‐d total IgG immunoassay and pseudovirion‐ d neutralization assay for a 14‐valent recombinant human papillomavirus vaccine
2022-08-30 -
Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters
2022-08-30